Despite a recent decision by the Second Circuit suggesting that anti-steering contractual provisions in other industries may not be anticompetitive, DOJ’s lawsuit (United States v. Carolinas HealthCare System) against Carolinas HealthCare System’s (CHS’s) contracting practices continues forward after surviving a motion for judgment on the pleadings.
Latest Post
More Posts
Price discrimination in the pharmaceutical sector: new decision, but plaintiffs face same challenges
Outlook for 2015: Antitrust Litigation in the Pharma Industry – More Than Just Actavis Progeny
FTC seeks comments on proposed divestiture study
FTC Seeks Comments on Proposed Divestiture Study
Flakeboard and SierraPine Pay Civil Penalties and Disgorgement of Profits to Settle DOJ’s Charges of Unlawful Gun Jumping
Federal Circuit Revives Certain Sham Petitioning Antitrust Counterclaims in Tyco-Mutual ANDA Litigation
FTC Director Addresses Enforcement Efforts in the Healthcare Sector
DOJ and FTC to Shine Spotlight on Analysis of Conditional Pricing Practices Under the Antitrust Laws
CT AG Leads Charge to Increase Transparency of Hospital-Physician Acquisitions and Facility Fees
Subscribe: Subscribe via RSS
Blogs
Firm/Org